No abstract available
Publication types
-
Case Reports
-
Comment
-
Letter
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Benzamides
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Male
-
Middle Aged
-
Piperazines / adverse effects
-
Pyrimidines / adverse effects
-
Tumor Lysis Syndrome / etiology
-
Tumor Lysis Syndrome / urine*
-
Uric Acid / urine*
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Uric Acid
-
Imatinib Mesylate